Indivior declares $8.13 special dividend contingent on merger close
Indivior Pharmaceuticals declared a $8.13 per share special cash dividend subject to the closing of its merger with Supernus Pharmaceuticals. The dividend is set to be paid on or about November 6, 2026, if the deal consummates.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed